Understanding Hyperlactatemia in Human Sepsis: Are We Making Progress?
To the Editor:
We have significant concerns about the interpretation of the data presented by Gattinoni and colleagues (1) . The reminders that lactic acidosis commonly coexists with renal acidosis and that metabolic acidosis does not necessarily mean acidemia are welcome. Indeed, one should dissociate hyperlactatemia from acidosis because hyperlactatemia can be of hypoxic origin even in the absence of acidosis, and of nonhypoxic origin even when there is acidemia (2) . Although we agree with Gattinoni and colleagues that a pH measurement can be misleading, and that lactate concentrations should be measured directly, neither the presence or absence of metabolic acidosis nor the central venous oxygen saturation (Scv O 2 ) value can help identify the origin of hyperlactatemia.
Gattinoni and colleagues also reemphasize the well-known fact that hyperlactatemia can coexist with any value of V :
. This is in part related to timing, because an increase in DO 2 as a result of resuscitative efforts may result in a rapid increase in Sv O 2 but a much slower decrease in blood lactate levels. More importantly, a normal or high Scv O 2 does not necessarily indicate that tissue perfusion is adequate. It is well known that a high Sv O 2 can be a sign of disease severity and worse prognosis (3). However, a high Sv O 2 does not always imply a significant alteration in cellular metabolism, as high Sv O 2 values can be the result of microcirculatory alterations. In our early study demonstrating the occurrence of microvascular alterations in sepsis (4), Sv O 2 values were identical in patients with sepsis and in other ICU patients, but hyperlactatemia was observed only in patients with septic shock (4). Accordingly, it may be erroneous and even potentially harmful to limit resuscitation efforts in a patient with hyperlactatemia just because his or her Scv high. When associated with signs of tissue hypoperfusion, an elevated Sv O 2 (or Scv O 2 ) does not mean that resuscitation efforts are no longer necessary. We previously reported that elevated Sv O 2 values did not exclude fluid responsiveness in patients with sepsis and signs of tissue hypoperfusion (5) . Similarly, Monnet and colleagues showed that blood lactate and venoarterial PCO 2 differences, but not Scv O 2 , predicted an increase in V : O 2 in fluidresponsive patients (6) .
Hence, we do not think that the observations by Gattinoni and colleagues should influence the way in which patients with sepsis are managed. Hyperlactatemia associated with other signs of tissue hypoperfusion should encourage attempts to increase DO 2 with fluids, transfusions, and/or dobutamine administration, even in the absence of acidemia or when ScvO 2 is not reduced. n 
Reply to Nalos and Robergs and to De Backer and Vincent

From the Authors:
We thank Professors Nalos and Robergs for their supportive comments concerning our paper and our hypotheses (1), particularly with regard to the lack of a direct causal relationship between elevated lactate and acidemia in patients with sepsis. Moreover, we agree that the cause of hyperlactatemia is often multifactorial and that the use of catecholamines is certainly a well-accepted contributor. In our population, lactate and epinephrine were weakly but significantly related (R 2 = 0.06; P , 0.0001). Professors De Backer and Vincent disagree with us on several points, which deserve a point-by-point reply.
1. They stated that "hyperlactatemia can be of hypoxic origin even in the absence of acidosis, and of nonhypoxic origin even when there is acidemia." The confusion here might stem from confounding of the terms "acidosis" and "acidemia." As soon as it is released into the blood, lactate (a strong negative ion) causes acidemia. If the measured pH does not fall, it simply means that other cofactors are operating. In our 1,741 patients with sepsis, the primary cofactor that determined acidemia was kidney function. Therefore, the relationship between acidemia and lactate has nothing to do with lactate origin. 2. They stated that "high Sv O 2 values can be the result of microcirculatory alterations." Actually, in their own cited work, they showed that microcirculation was altered in patients with sepsis compared with patients without sepsis, but venous oxygen saturation (Sv O 2 ) values were similar. 3. They stated that elevated Scv O 2 is compatible with inadequate perfusion (due to peripheral shunt), thus implying a need for further fluid resuscitation. This argument reflects the common belief that if peripheral shunt increases, the Scv O 2 will increase despite inadequate oxygen delivery. The validity of this concept may be tested by considering the periphery as comprised of two compartments: one oxygen consuming (V 
